Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer

Bernard Escudier, Viktor Grünwald, Alain Ravaud, Yen Chuan Ou, Daniel Castellano, Chia Chi Lin, Jürgen E. Gschwend, Andrea Harzstark, Sarah Beall, Nicoletta Pirotta, Matthew Squires, Michael Shi, Eric Angevin

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II results of dovitinib (TKI258) in patients with metastatic renal cell cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science